<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="other" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Pediatric Hematology/Oncology and Immunopathology</journal-id><journal-title-group><journal-title xml:lang="en">Pediatric Hematology/Oncology and Immunopathology</journal-title><trans-title-group xml:lang="ru"><trans-title>Вопросы гематологии/онкологии и иммунопатологии в педиатрии</trans-title></trans-title-group></journal-title-group><issn publication-format="print">1726-1708</issn><issn publication-format="electronic">2414-9314</issn><publisher><publisher-name xml:lang="en">Fund Doctors, Innovations, Science for Children</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">169</article-id><article-id pub-id-type="doi">10.24287/1726-1708-2016-15-3-40-45</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>CLINICAL OBSERVATIONS</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>КЛИНИЧЕСКИЕ НАБЛЮДЕНИЯ</subject></subj-group><subj-group subj-group-type="article-type"><subject></subject></subj-group></article-categories><title-group><article-title xml:lang="en">Specificities of the course of Wiscott-Aldrich syndrome depending on WASP gene mutations</article-title><trans-title-group xml:lang="ru"><trans-title>Особенности течения синдрома Вискотта-Олдрича в зависимости от мутаций гена WASP</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Didkovskiy</surname><given-names>Nikolay A.</given-names></name><name xml:lang="ru"><surname>Дидковский</surname><given-names>Николай Антонович</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><email>didcovskinic@gmail.com</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Krynskiy</surname><given-names>Sergey A.</given-names></name><name xml:lang="ru"><surname>Крынский</surname><given-names>Сергей Андреевич</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><email>srgkr002@gmail.com</email><xref ref-type="aff" rid="aff1"/><xref ref-type="aff" rid="aff2"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Malashenkova</surname><given-names>Irina K.</given-names></name><name xml:lang="ru"><surname>Малашенкова</surname><given-names>Ирина Константиновна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><email>malashenkova.irina@bk.ru</email><xref ref-type="aff" rid="aff2"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Raykina</surname><given-names>Elena V.</given-names></name><name xml:lang="ru"><surname>Райкина</surname><given-names>Елена Владиславовна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><email>e_raikina@inbox.ru</email><xref ref-type="aff" rid="aff3"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Varlamova</surname><given-names>Tatyana V.</given-names></name><name xml:lang="ru"><surname>Варламова</surname><given-names>Татьяна Владимировна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><email>varltatwell@mail.ru</email><xref ref-type="aff" rid="aff3"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">Federal Research and Clinical Centre of Physico-Chemical Medicine, Russian Federal Medical-Biological Agency</institution></aff><aff><institution xml:lang="ru">Федеральный научно-клинический центр физико-химической медицины Федерального медико-биологического агентства России</institution></aff></aff-alternatives><aff-alternatives id="aff2"><aff><institution xml:lang="en">National Research Centre «Kurchatov Institute»</institution></aff><aff><institution xml:lang="ru">Национальный исследовательский центр «Курчатовский институт»</institution></aff></aff-alternatives><aff-alternatives id="aff3"><aff><institution xml:lang="en">Dmitry Rogachev Federal Research Centre of Paediatric Haematology, Oncology and Immunology, Ministry of Health of the Russian Federation</institution></aff><aff><institution xml:lang="ru">Федеральный научно-клинический центр детской гематологии, онкологии и иммунологии им. Дмитрия Рогачева Минздрава России</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2016-09-19" publication-format="electronic"><day>19</day><month>09</month><year>2016</year></pub-date><volume>15</volume><issue>3</issue><issue-title xml:lang="en"/><issue-title xml:lang="ru"/><fpage>40</fpage><lpage>45</lpage><history><date date-type="received" iso-8601-date="2018-09-19"><day>19</day><month>09</month><year>2018</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2016, «D. Rogachev NMRCPHOI»</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2016, ФГБУ «НМИЦ ДГОИ им. Дмитрия Рогачева» Минздрава России</copyright-statement><copyright-year>2016</copyright-year><copyright-holder xml:lang="en">«D. Rogachev NMRCPHOI»</copyright-holder><copyright-holder xml:lang="ru">ФГБУ «НМИЦ ДГОИ им. Дмитрия Рогачева» Минздрава России</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">https://creativecommons.org/licenses/by/4.0</ali:license_ref></license></permissions><self-uri xlink:href="https://hemoncim.com/jour/article/view/169">https://hemoncim.com/jour/article/view/169</self-uri><abstract xml:lang="en"><p>Wiscott-Aldrich syndrome (WAS) is a rare X-liked recessive disease caused by mutation of the WASP gene. Disease is characterized by microthrombocytopenia, disorders of cell-mediated and humoral immunity, bleeding, eczema, frequent occurrence of infections, autoimmune diseases and malignancies. The article presents recent evidence about the role of WASP protein in the mechanisms of haemostasis and immune defence, discusses hypotheses for molecular mechanisms of WAS pathogenesis and interrelations between particular WASP gene mutations and clinical manifestations of disease. The review is illustrated by a clinical case of WAS with untypical clinical manifestations and absence of microthrombocytopenia illustrates.</p></abstract><trans-abstract xml:lang="ru"><p>Синдром Вискотта-Олдрича (СВО) - редкое заболевание, наследуемое по Х-сцепленному рецессивному типу, причиной которого являются мутации гена WASP. Болезнь характеризуется микротромбоцитопенией, нарушениями клеточного и гуморального иммунитета, кровотечениями, экземой, повышенной частотой инфекций, аутоиммунных заболеваний и злокачественных новообразований. В статье приводятся современные данные о роли белка WASP в механизмах гемостаза и иммунной защиты, рассматриваются предполагаемые молекулярные механизмы патогенеза СВО, обсуждается взаимосвязь между конкретными мутациями гена WASP и клиническими проявлениями заболевания. Для иллюстрации приводится клиническое наблюдение СВО с нетипичными клиническими проявлениями и отсутствием микротромбоцитопении.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>микротромбоцитопения</kwd><kwd>синдром Вискотта-Олдрича</kwd><kwd>Х-сцепленная тромбоцитопения</kwd><kwd>microthrombocytopenia</kwd><kwd>Wiscott-Aldrich syndrome</kwd><kwd>X-linked thrombocytopenia</kwd></kwd-group></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Primary immunodeficiency diseases. Report of an IUIS Scientific Committee. International Union of Immunological Societies. Clin Exp Immunol. 1999; 118(Suppl. 1):1-28.</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Bouma G, Burns SO, Thrasher AJ. Wiskott-Aldrich syndrome: immunodeficiency resulting from defective cell migration and impaired immunostimulatory activation. Immunobiology. 2009;214(9-10):778-90.</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Liu DW, Zhang ZY, Zhao Q, Jiang LP, Liu W, Tu WW, et al. Wiskott-Aldrich syndrome/X-linked thrombocytopenia in China: clinical characteristic and genotype-phenotype correlation. Pediatr Blood Cancer. 2015;62(9):1601-8.</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Moratto D, Giliani S, Notarangelo LD, Mazza C, Mazzolari E, Notarangelo LD. The Wiskott-Aldrich syndrome: from genotype-phenotype correlation to treatment. Expert Rev Clin Immunol. 2007;3(5):813-24.</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Пащенко ОЕ, Кондратенко ИВ, Бологов АА. Аутоиммунные проявления при синдроме Вискотта-Олдрича. Детская больница. 2014;3(57):14-21</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Albert MH, Bittner TC, Nonoyama S, Notarangelo LD, Burns S, Imai K, et al. X-linked thrombocytopenia (XLT) due to WAS mutations: clinical characteristics, long-term outcome, and treatment options. Blood. 2010;115(16):3231-8.</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>Ochs HD, Filipovich AH, Veys P, Cowan MJ, Kapoor N. Wiskott-Aldrich syndrome: diagnosis, clinical and laboratory manifestations, and treatment. Biol Blood Marrow Transplant. 2009;15(1, Suppl):84-90.</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>Imai K, Morio T, Zhu Y, Jin Y, Itoh S, Kajiwara M, et al. Clinical course of patients with WASP gene mutations. Blood. 2004;103(2):456-64.</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>Ochs HD. Mutations of the Wiskott-Aldrich syndrome protein affect protein expression and dictate the clinical phenotypes. Immunol Res. 2009;44(1-3):84-8.</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>Wiskott A. Familiarer angeborener Morbus Werlhofii. Monastsschr. Monastsschr. Kinderleil. Kd. 1937;68:212-6.</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>Blundell MP, Worth A, Bouma G, Thrasher AJ. The Wiskott-Aldrich syndrome: the actin cytoskeleton and immune cell function. Dis Markers. 2010;29(3-4):157-75.</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation>Sarkar K, Sadhukhan S, Han SS, Vyas YM. Disruption of hSWI/SNF complexes in T cells by WAS mutations distinguishes X-linked thrombocytopenia from Wiskott-Aldrich syndrome. Blood. 2014;124(23):3409-19.</mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation>Calle Y, Jones GE, Jagger C, Fuller K, Blundell MP, Chow J, et al. WASp deficiency in mice results in failure to form osteoclast sealing zones and defects in bone resorption. Blood. 2004;103(9):3552-61.</mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation>Lorenzi R, Brickell PM, Katz DR, Kinnon C, Thrasher AJ. Wiskott-Aldrich syndrome protein is necessary for efficient IgG-mediated phagocytosis. Blood. 2000; 95(9):2943-6.</mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation>Gismondi A, Cifaldi L, Mazza C, Giliani S, Parolini S, Morrone S, et al. Impaired natural and CD16-mediated NK cell cytotoxicity in patients with WAS and XLT: ability of IL-2 to correct NK cell functional defect. Blood. 2004;104(2):436-43.</mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation>Dahlberg CI, Torres ML, Petersen SH, Baptista MA, Keszei M, Volpi S, et al. Deletion of WASp and N-WASp in B cells cripples the germinal center response and results in production of IgM autoantibodies. J Autoimmun. 2015;62:81 -92.</mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation>Recher M, Burns SO, de la Fuente MA, Volpi S, Dahlberg C, Walter JE, et al. B cell-intrinsic deficiency of the Wiskott-Aldrich syndrome protein (WASp) causes severe abnormalities of the peripheral B-cell compartment in mice. Blood. 2012;119(12):2819-28.</mixed-citation></ref><ref id="B18"><label>18.</label><mixed-citation>Шарапова ОШ, Пащенко ОЕ, Гурьянова ИЕ, Мигас АА, Кондратенко ИВ, Белевцев МВ. Сравнительный анализ фенотипа Т и В-лимфоцитов при аутоиммунном лимфопролиферативном синдроме и синдроме Вискотта-Олдрича. Иммунопатология, аллергология, инфектология. 2013;4:67-80.</mixed-citation></ref><ref id="B19"><label>19.</label><mixed-citation>Becker-Herman S, Meyer-Bahlburg A, Schwartz MA, Jackson SW, Hudkins KL, Liu C, et al. WASp-deficient B cells play a critical, cell-intrinsic role in triggering autoimmunity. J Exp Med. 2011;208(10):2033-42.</mixed-citation></ref><ref id="B20"><label>20.</label><mixed-citation>Ingrungruanglert P, Amarinthnukrowh P, Rungsiwiwut R, Maneesri-le Grand S, Sosothikul D, Suphapeetiporn K, et al. Wiskott-Aldrich syndrome iPS cells produce megakaryocytes with defects in cytoskeletal rearrangement and proplatelet formation. Thromb Haemost. 2015;113(4):792-805.</mixed-citation></ref><ref id="B21"><label>21.</label><mixed-citation>Poulter NS, Pollitt AY, Davies A, Malinova D, Nash GB, Hannon MJ, et al. Platelet actin nodules are podosome-like structures dependent on Wiskott-Aldrich syndrome protein and ARP2/3 complex. Nat Commun. 2015;6:7254.</mixed-citation></ref><ref id="B22"><label>22.</label><mixed-citation>Schwarz K. WASPbase: a database of WAS- and XLT-causing mutations. Immunol Today. 1996;17(11):496-502.</mixed-citation></ref><ref id="B23"><label>23.</label><mixed-citation>Gul6csy V, Freiberger T, Shcherbina A, Pac M, Chernyshova L, Avcin T, et al. Genetic characteristics of eighty-seven patients with the Wiskott-Aldrich syndrome. Mol Immunol. 2011;48(5):788-92.</mixed-citation></ref><ref id="B24"><label>24.</label><mixed-citation>Thrasher AJ. New insights into the biology of Wiskott-Aldrich syndrome (WAS). Hematology Am Soc Hematol Educ Program. 2009:132-8.</mixed-citation></ref><ref id="B25"><label>25.</label><mixed-citation>Imai K, Nonoyama S, Miki H, Morio T, Fukami K, Zhu Q, et al. The pleckstrin homology domain of the Wiskott-Aldrich syndrome protein is involved in the organization of actin cytoskeleton. Clin Immunol. 1999;92(2):128-37.</mixed-citation></ref><ref id="B26"><label>26.</label><mixed-citation>Jin Y, Mazza C, Christie JR, Giliani S, Fiorini M, Mella P, et al. Mutations of the Wiskott-Aldrich syndrome protein (WASP): hotspots, effect on transcription, and translation and phenotype/genotype correlation. Blood. 2004;104(13):4010-9.</mixed-citation></ref><ref id="B27"><label>27.</label><mixed-citation>WASbase. Variation registry for Wiskott-Aldrich syndrome (WAS). Protein Structure and Bioinformatics, Lund University, 2015.</mixed-citation></ref><ref id="B28"><label>28.</label><mixed-citation>Kang JW, Kim GN, Kim SY, Kim HJ, Park ES, Kim JY, et al. Clinical and radiologic evaluation of cytomegalovirus-induced thrombocytopenia in infants between 1 and 6 months of age. Korean J Hematol. 2010;45(1):29-35.</mixed-citation></ref></ref-list></back></article>
